111 related articles for article (PubMed ID: 37271222)
1. Lemur tyrosine kinase 2 has a tumor-inhibition function in human glioblastoma by regulating the RUNX3/Notch pathway.
Zhang L; Luo P; Mao X; Sun J; Wei J; Yang Y; Zhang Y; Jiang X
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119509. PubMed ID: 37271222
[TBL] [Abstract][Full Text] [Related]
2. POFUT1 acts as a tumor promoter in glioblastoma by enhancing the activation of Notch signaling.
Li Q; Wang J; Ma X; Wang M; Zhou L
J Bioenerg Biomembr; 2021 Oct; 53(5):621-632. PubMed ID: 34251584
[TBL] [Abstract][Full Text] [Related]
3. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
[TBL] [Abstract][Full Text] [Related]
4. Lemur tyrosine kinase 2 silencing inhibits the proliferation of gastric cancer cells by regulating GSK-3β phosphorylation and β-catenin nuclear translocation.
Han X; Wang DZ; Yuan M; Bai WJ
Bioengineered; 2022 Mar; 13(3):6231-6243. PubMed ID: 34719320
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
[TBL] [Abstract][Full Text] [Related]
6. Lemur Tyrosine Kinase 2, a novel target in prostate cancer therapy.
Shah K; Bradbury NA
Oncotarget; 2015 Jun; 6(16):14233-46. PubMed ID: 26008968
[TBL] [Abstract][Full Text] [Related]
7. Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling.
Alafate W; Xu D; Wu W; Xiang J; Ma X; Xie W; Bai X; Wang M; Wang J
J Exp Clin Cancer Res; 2020 Nov; 39(1):239. PubMed ID: 33176854
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Notch signaling activation to human glioblastoma multiforme.
Kanamori M; Kawaguchi T; Nigro JM; Feuerstein BG; Berger MS; Miele L; Pieper RO
J Neurosurg; 2007 Mar; 106(3):417-27. PubMed ID: 17367064
[TBL] [Abstract][Full Text] [Related]
9. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines.
Reichrath S; Müller CS; Gleissner B; Pfreundschuh M; Vogt T; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):420-4. PubMed ID: 20206691
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of lemur tyrosine kinase-2 protects neurons from oxygen-glucose deprivation/reoxygenation-induced injury through reinforcement of Nrf2 signaling by modulating GSK-3β phosphorylation.
Bao H; Gao M
Biochem Biophys Res Commun; 2020 Jan; 521(4):964-970. PubMed ID: 31722791
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
[TBL] [Abstract][Full Text] [Related]
12. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme.
Gersey Z; Osiason AD; Bloom L; Shah S; Thompson JW; Bregy A; Agarwal N; Komotar RJ
World Neurosurg; 2019 Nov; 131():252-263.e2. PubMed ID: 31376551
[TBL] [Abstract][Full Text] [Related]
14. Lemur tyrosine kinase 2 (LMTK2) is a determinant of cell sensitivity to apoptosis by regulating the levels of the BCL2 family members.
Conti A; Majorini MT; Fontanella E; Bardelli A; Giacca M; Delia D; Mano M; Lecis D
Cancer Lett; 2017 Mar; 389():59-69. PubMed ID: 28040547
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
[TBL] [Abstract][Full Text] [Related]
17. Lemur tyrosine kinase 2 acts as a positive regulator of NF-κB activation and colon cancer cell proliferation.
Zhang R; Li X; Wei L; Qin Y; Fang J
Cancer Lett; 2019 Jul; 454():70-77. PubMed ID: 30980866
[TBL] [Abstract][Full Text] [Related]
18. Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt.
El-Sehemy A; Selvadurai H; Ortin-Martinez A; Pokrajac N; Mamatjan Y; Tachibana N; Rowland K; Lee L; Park N; Aldape K; Dirks P; Wallace VA
J Clin Invest; 2020 Jun; 130(6):3069-3086. PubMed ID: 32182224
[TBL] [Abstract][Full Text] [Related]
19. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.
Floyd DH; Kefas B; Seleverstov O; Mykhaylyk O; Dominguez C; Comeau L; Plank C; Purow B
Neuro Oncol; 2012 Oct; 14(10):1215-26. PubMed ID: 22962413
[TBL] [Abstract][Full Text] [Related]
20. Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme.
El Hindy N; Keyvani K; Pagenstecher A; Dammann P; Sandalcioglu IE; Sure U; Zhu Y
Neuro Oncol; 2013 Oct; 15(10):1366-78. PubMed ID: 23787764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]